26519339|t|Memantine ER/Donepezil: A Review in Alzheimer's Disease.
26519339|a|A once-daily, fixed-dose combination of memantine extended-release (ER)/donepezil 28/10 mg (Namzaric ) is available in the USA for patients with moderate to severe Alzheimer's disease (AD) on stable memantine and donepezil therapy. The fixed-dose formulation is bioequivalent to coadministration of the individual drugs. In a 24-week, phase III trial in patients with moderate to severe AD, addition of memantine ER 28 mg once daily to stable cholinesterase inhibitor (ChEI) therapy was more effective than add-on placebo on measures of cognition, global clinical status, dementia behaviour and semantic processing ability, although between-group differences on a measure of daily function did not significantly differ. In subgroup analyses in donepezil-treated patients, add-on memantine ER was more effective than add-on placebo on measures of cognition, dementia behaviour and semantic processing, although there were no significant between-group differences on measures of global clinical status and daily function. Memantine ER plus ChEI combination therapy was generally well tolerated in the phase III trial, with diarrhoea, dizziness and influenza occurring at least twice as often with add-on memantine ER as add-on placebo in donepezil-treated patients. Thus, memantine ER plus donepezil combination therapy is an effective and well tolerated treatment option for patients with moderate to severe AD. The fixed-dose combination is potentially more convenient than coadministration of the individual agents. 
26519339	0	12	Memantine ER	Chemical	-
26519339	13	22	Donepezil	Chemical	MESH:D000077265
26519339	36	55	Alzheimer's Disease	Disease	MESH:D000544
26519339	97	128	memantine extended-release (ER)	Chemical	-
26519339	129	138	donepezil	Chemical	MESH:D000077265
26519339	149	157	Namzaric	Chemical	MESH:C000610194
26519339	188	196	patients	Species	9606
26519339	221	240	Alzheimer's disease	Disease	MESH:D000544
26519339	242	244	AD	Disease	MESH:D000544
26519339	256	265	memantine	Chemical	MESH:D008559
26519339	270	279	donepezil	Chemical	MESH:D000077265
26519339	411	419	patients	Species	9606
26519339	444	446	AD	Disease	MESH:D000544
26519339	460	472	memantine ER	Chemical	-
26519339	629	637	dementia	Disease	MESH:D003704
26519339	801	810	donepezil	Chemical	MESH:D000077265
26519339	819	827	patients	Species	9606
26519339	836	848	memantine ER	Chemical	-
26519339	914	922	dementia	Disease	MESH:D003704
26519339	1077	1089	Memantine ER	Chemical	-
26519339	1178	1187	diarrhoea	Disease	MESH:D003967
26519339	1189	1198	dizziness	Disease	MESH:D004244
26519339	1203	1212	influenza	Disease	MESH:D007251
26519339	1259	1271	memantine ER	Chemical	-
26519339	1293	1302	donepezil	Chemical	MESH:D000077265
26519339	1311	1319	patients	Species	9606
26519339	1327	1339	memantine ER	Chemical	-
26519339	1345	1354	donepezil	Chemical	MESH:D000077265
26519339	1431	1439	patients	Species	9606
26519339	1464	1466	AD	Disease	MESH:D000544
26519339	Cotreatment	MESH:D000077265	MESH:D008559
26519339	Positive_Correlation	MESH:D000077265	MESH:D004244
26519339	Negative_Correlation	MESH:C000610194	MESH:D000544
26519339	Negative_Correlation	MESH:D000077265	MESH:D000544
26519339	Cotreatment	MESH:C000610194	MESH:D000077265
26519339	Negative_Correlation	MESH:D008559	MESH:D000544
26519339	Positive_Correlation	MESH:D000077265	MESH:D003967
26519339	Cotreatment	MESH:C000610194	MESH:D008559

